Biocryst Pharmaceuticals Inc (BCRX)
$7.65
Biocryst Pharmaceuticals Inc (BCRX) Share Price Forecast
Currently 17 wall-street analysts regularly analyze the financials of Biocryst Pharmaceuticals Inc on a frequent basis to provide recommendations along with target share price. 17 analysts offering 12-month price forecasts for Biocryst Pharmaceuticals Inc (BCRX) have a share price target of $15.1. This median of share price forecast represents a 97.39% upside from the latest price of $7.65 as on 21.09.23.
Biocryst Pharmaceuticals Inc (BCRX) Price vs Consensus Price Target
Price
Target Price
As per the chart shown above, analysts believe that the Biocryst Pharmaceuticals Inc (BCRX) share price will touch around $15.1 in next 12-months.
Biocryst Pharmaceuticals Inc (BCRX) Share Price Forecast v/s Share Price Today
Below is a chart showing the percentage difference between Biocryst Pharmaceuticals Inc's share price and its median forecast price. As on 21.09.23, the difference is -51.79%
Biocryst Pharmaceuticals Inc (BCRX): Difference between Current Price & Median Forecasted Price
Difference in Percentage terms
Biocryst Pharmaceuticals Inc (BCRX) Share Price : Analyst Recommendation
Based on 17 analysts tracking and researching Biocryst Pharmaceuticals Inc (BCRX) share have buy recommendation on an average.
| 3M Ago | 1M Ago | Current | |
| Buy | 10 | 10 | 9 |
| Outperform | 2 | 2 | 2 |
| Hold | 6 | 6 | 6 |
| Underperform | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 |
Biocryst Pharmaceuticals Inc (BCRX) Share Price Technical Analysis
50 Day Moving Average v/s Current Share Price
Moving Average
Price
200 Day Moving Average v/s Current Share Price
Moving Average
Price
FAQs
The latest share price target for Biocryst Pharmaceuticals Inc (BCRX) is $15.1, offered by 17 analysts offering 12-month price forecasts.
Biocryst Pharmaceuticals Inc (BCRX) has a maximum of 0.97 upside potential, based on 17 analysts offering 12-month price forecasts.
Based on 17 analysts tracking and researching Biocryst Pharmaceuticals Inc (BCRX), 64.71% have a buy recommendation. Remaining 35.29% have either sell or hold recommendations.
The latest share price of Biocryst Pharmaceuticals Inc (BCRX) is $7.65 as of 21/09/2023.
11 of total 17 analysts offering stock ratings for Biocryst Pharmaceuticals Inc BCRX have recommended buy rating.
₹0 US Stocks a/c Opening Fee